The in vivo processes responsible for misfolding of native precursors, for formation of amyloid fibrils, and for the anatomical localization of amyloid deposition are not known either for transthyretin (TTR)4 or for other types of systemic amyloidosis (1). The gene discussed is TTR; the disease is primary systemic amyloidosis.